Our
Tests

Set on improving health
outcomes one test at a time.

Our
Testing

Set on improving health
outcomes one test at a time.

Search for Testing or FAQs

Ensuring the right diagnosis and increasing patient satisfaction through precise, CDC-recommended highly-sensitive nucleic acid detection and innovative specimen collection.

SimplySTI is an innovative multiplex PCR and serology-based platform which provides fast, highly sensitive, specific, and accurate detection of the major pathogens associated with sexually transmitted infections (STI).

  • Most comprehensive test menu covering 13 STI associated pathogens

  • Simultaneous detection of multiple STI pathogens from a single specimen

  • Multiple sample types accepted: saliva, urine, blood, vaginal swab, lesion swab

  • Better detection rate compared to culture-based technologies (18% vs. 3%)*

SimplySTI has one of the most expansive sample type offerings for STI testing, which includes the first saliva-based clinical assay for Mpox (Monkeypox).

*Comprehensive Screening for Sexually Transmitted Pathogens.  Medlab Management.  Sept-Oct. 2014. Vol 3 #5

Diagnose and monitor the treatment of hormonal disorders reliably, accurately, and pain-free using saliva. Reports demonstrate an increase in overall test participation & on-going compliance with frequent testing regimens when saliva is offered.*
(+ Saliva Benefits)

  • Testosterone x1

  • Cortisol x1

  • Cortisol-24 (x3)

  • Estradiol x1

  • Progesterone x1

  • DHEA x1

  • General Check

  • E2, Pg, T, DHEA, Cortisol x 1

*Dhima, M., Salinas, T. J., Wermers, R. A., Weaver, A. L., & Koka, S. (2013). Preference changes of adult outpatients for giving saliva, urine and blood for clinical testing after actual sample collection. Journal of prosthodontic research, 57(1), 51–56. https://doi.org/10.1016/j.jpor.2012.09.004

Periodontitis is a common immune-inflammatory oral disease. Early detection of clinically important microorganisms contribute to the development and progression of periodontal disease.

  • Periodontal disease is highly prevalent, estimated at 47.2% of the general population for individuals over 30, and 70.1% for individuals over 65.

  • SimplyPerio® is a 17-plex microbial snapshot examining the presence and quantity of multiple organisms that contribute to all stages of periodontal disease.

  • SimplyPerio® testing includes the bacteria Pseudomonas Aeruginosa for its role in dental implant failures.

  • Biofilm often contain harmful bacteria including Fusobacterium, Streptococcus, Prevotella, Porphyromonas, & Actinomyces.

  • Noninvasive testing drives early detection, effective treatment, & disease monitoring and prevention.

  • Testing drives clinical insights for an informed hand off and medical diagnosis opportunity.

  • Testing empowers holistic patient understanding and offers true life-saving treatment.

  • Testing adds practice value, drives patient loyalty, & delivers the highest level of patient care.

Nearly all sexually active people are infected with HPV within months to a few years of becoming sexually active. Around half of these infections are with a high-risk type.*

  • SimplyHPV™ is a test for the qualitative and simultaneous molecular detection of 14 high-risk HPV types in a single test.

  • Test specifically identifies HPV 16 & HPV 18 while concurrently detecting (31, 33, 35, 39, 45, 51, 56, 58, 59, 66, and 68).

  • HPV tests are more accurate than Pap alone.

  • The specificity of HPV is superior so the testing interval is longer.

  • The American Society for Clinical Pathologists (ASCP), recommends screening for all women starting at age 21 through 65.

  • In the United States, there are approximately 79 million infections and 14 million new infections each year.*

  • HPV infections are usually transient & asymptomatic.*

*Satterwhite CL, Torrone E, Meites E, et al. Sex Transm Dis 2013 Mar;40(3):18793 Winer RL, Lee SK, Hughes JP, et al. Am J Epidemiol 2003;157:218–2

Establish Your Provider
Account

Establish your Provider
Account